Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00953017 · ClinicalTrials.gov registry record · Phase 4
A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy
A Phase 4 study of Colonoscopy, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 425
- Enrollment target
- 1
- Study location
NCT00953017 is a Phase 4 study of Colonoscopy that has completed, run by Brooke Army Medical Center. The registered enrollment target is 425 participants, below the 480-participant average among 20 other Colonoscopy trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00953017, a Phase 4 study of Colonoscopy, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 425 participants
- Enrollment target
- 1
- Study location
Study Summary
Miralax (PEG 3350) has been shown to be a safe and uncomplicated bowel preparation prior to colonoscopy in pediatric populations. This study seeks to confirm the efficacy of this bowel cleansing regimen in adults and to determine the benefit of adding a pretreatment medication to this bowel preparation. The tolerability of Miralax will hopefully improve patient satisfaction with colonoscopy and decrease their reluctance to be screened because of the uncomfortable taste and side effects of bowel preparation regimens.
Conditions Studied
Interventions
- DRUG Miralax (PEG 3350)
- DRUG Amitiza (Lubiprostone)
- DRUG Dulcolax (Bisacodyl)
- DRUG Golytely (polyethylene glycol)
Study Locations (1)
Texas
- Brooke Army Medical Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 425 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00953017
The ClinicalTrials.gov registry entry for NCT00953017 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 425 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 480-participant average among 20 other Colonoscopy trials with a reported enrollment target (11% lower). The listed sponsor is Brooke Army Medical Center, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colonoscopy appearing as the primary indexed condition, and to 4 interventions - of which Miralax (PEG 3350) is the first listed.
NCT00953017 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00953017 about?
NCT00953017 is a clinical study titled "A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy". Miralax (PEG 3350) has been shown to be a safe and uncomplicated bowel preparation prior to colonoscopy in pediatric populations. This study seeks to confirm the efficacy of this bowel cleansing regimen in adults and to determine the benefit of adding a pretreatment medication to this bowel preparat...
What is the current status of trial NCT00953017?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 425 participants. The study started on 2009-07. Estimated completion is 2010-05.
What conditions does trial NCT00953017 study?
This clinical trial studies the following conditions: Colonoscopy.
What interventions are being tested in trial NCT00953017?
The interventions under investigation include: Miralax (PEG 3350) (DRUG), Amitiza (Lubiprostone) (DRUG), Dulcolax (Bisacodyl) (DRUG), Golytely (polyethylene glycol) (DRUG).
Who is sponsoring clinical trial NCT00953017?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00953017 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
RECRUITING
-
Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study
RECRUITING
-
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
RECRUITING · NA
-
Cold Snare Endoscopic Mucosal Resection Trial
ACTIVE NOT RECRUITING · NA
-
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.